Molecular origins of cancer: Epigenetics in cancer

被引：2005

作者：

Esteller, Manel ^{[1
]}

机构：

[1] Spanish Natl Canc Res Ctr, Canc Epigenet Lab, Madrid 28029, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 11期

关键词：

D O I：

10.1056/NEJMra072067

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gene transcription can be activated or inhibited by a reversible modification of the gene; this modification is termed an epigenetic change. This account of epigenetics in cancer reviews the mechanisms and consequences of epigenetic changes in cancer cells and concludes with the implications of these changes for the diagnosis, prognosis, and treatment of cancer. Copyright © 2008 Massachusetts Medical Society. All rights reserved.

引用

页码：1148 / 1159

页数：12

共 108 条

[31]

Esteller M, 2002, J NATL CANCER I, V94, P26

[32]

Esteller M, 1999, CANCER RES, V59, P3853

[33] Cancer epigenomics: DNA methylomes and histone-modification maps [J].

Esteller, Manel .

NATURE REVIEWS GENETICS, 2007, 8 (04) :286-298

[34] Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid [J].

Fackler, Mary Jo ;

Malone, Kara ;

Zhang, Zhe ;

Schilling, Eric ;

Garrett-Mayer, Elizabeth ;

Swift-Scanlan, Theresa ;

Lange, Julie ;

Nayar, Ritu ;

Davidson, Nancy E. ;

Khan, Seema A. ;

Sukumar, Saraswati .

CLINICAL CANCER RESEARCH, 2006, 12 (11) :3306-3310

[35]

Feinberg AP, 1999, CANCER RES, V59, p1743S

[36] HYPOMETHYLATION DISTINGUISHES GENES OF SOME HUMAN CANCERS FROM THEIR NORMAL COUNTERPARTS [J].

FEINBERG, AP ;

VOGELSTEIN, B .

NATURE, 1983, 301 (5895) :89-92

[37] Timeline - The history of cancer epigenetics [J].

Feinberg, AP ;

Tycko, B .

NATURE REVIEWS CANCER, 2004, 4 (02) :143-153

[38] DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms [J].

Feinberg, AP ;

Cui, HM ;

Ohlsson, R .

SEMINARS IN CANCER BIOLOGY, 2002, 12 (05) :389-398

[39] Detection of hypermethylated genes in women with and without cervical neoplasia [J].

Feng, QH ;

Balasubramanian, A ;

Hawes, SE ;

Toure, P ;

Sow, PS ;

Dem, A ;

Dembele, B ;

Critchlow, CW ;

Xi, LF ;

Lu, H ;

McIntosh, MW ;

Young, AM ;

Kiviat, NB .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (04) :273-282

[40] Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas [J].

Ferreri, AJM ;

Dell'Oro, S ;

Capello, D ;

Ponzoni, M ;

Iuzzolino, P ;

Rossi, D ;

Pasini, F ;

Ambrosetti, A ;

Orvieto, E ;

Ferrarese, F ;

Arrigoni, G ;

Foppoli, M ;

Reni, M ;

Gaidano, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (05) :657-664

← 1 2 3 4 5 6 7 8 9 10 →